Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Zheng Yabing
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Age 18 years or older.
Histologically confirmed advanced breast cancer, defined as locally recurrent disease not suitable for curative treatment or metastatic disease.
First recurrence or metastasis, or documented disease progression during palliative treatment, with a planned new systemic anticancer treatment regimen.
Estimated life expectancy of at least 3 months.
Ability and willingness to provide written informed consent.
You may not be if
Early-stage breast cancer.
Ongoing systemic anticancer treatment without a need to change to a new treatment regimen.
Pregnant or breastfeeding women.
Any condition or other reason that, in the investigator's judgment, makes the participant unsuitable for enrollment.
Clareo Health | Mecapegfilgrastim for Prevention of Chemotherapy-Induced Neutropenia in Advanced Breast Cancer
